The relationship of metabolic syndrome, serum leptin levels and treatment in bipolar disorder;İkiuçlu bozuklukta metabolik sendrom, serum leptin düzeyleri ve tedavi i̇lişkisi

Klinik Psikofarmakoloji Bulteni

Volumn 18, Issue 2, 2008, Pages 79-83

  Yumru, Mehmet ^d   Savaş, Esen ^a,b   Gergerlioǧlu, H Serdar ^c   Başarali, Kemal ^c   Kalenderoǧlu, Aysun ^a   Savaş, Haluk A ^a   Büyükbaş, Sadik ^c  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Cengiz Gokcek Devlet Hastanesi   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

^d NONE

Author keywords

Atypical antipsychotics; Bipolar disorder; Leptin; Metabolic syndrome

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LEPTIN; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ABDOMINAL OBESITY; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL;

EID: 46349096621     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, ScottStroup T, Lieberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80: 19-32
2. Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003; 64: 575-579
3. Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G. Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can J Psychiatry 2004; 49: 753-760
4. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005; 7: 424-430
5. Basu R, Brar JS, Chengappa KNR, John V, Parepally H, Gershon S, Schlicht P, Kupfer DJ. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype. Bipolar Disord 2004; 6: 314-318
6. Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savaş E, Oral ET, Atagün İ. Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord 2007; 98: 247-252
7. Prolo P, Wong ML, Licino J. Leptin. Int J Biochem Cell Biol 1998; 30: 1285-1290
8. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432
9. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001; 104: 531-543
10. Sahu A. Minireview: A hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 2004; 145: 2613-2620
11. Atmaca M, Kuloglu M, Tezcan E, Gecici O, Ustundag B. Serum cholesterol and leptin levels in patients with borderline personality disorder. Neuropsychobiology 2002; 45: 167-171
12. Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Gecici O, Firidin B. Serum leptin and cholesterol values in the suicide attempters. Neuropsychobiology 2002; 45: 124-127
13. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Serum cholesterol and leptin levels in patients with bipolar disorders. Neuropsychobiology 2002; 46: 176-179
14. Atmaca M, Kuloglu M, Tezcan E, Gecici O, Ustundag B. Weight gain, serum leptin and triglyceride levels in the patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol. Schizophr Res 2003; 60: 99-100
15. Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T: Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 2001; 73: 243-247
16. Yurtsever F, Danaci AE, Taneli F, Günay Ö, Veznedaroǧlu B. Atipik antipsikotik kullanan hastalarda ailede diyabet öyküsü olmasinin glukoz metabolizmasi üzerine olan etkileri. Klinik Psikofarmakoloji Bülteni 2007; 17; 111-118
17. Usta E, Metin Ö, Birsöz S. Şizofreni ve diyabet: Yeni kuşak antipsikotiklerin yol açtiǧi diyabet veya metabolik sendrom. Klinik Psikofarmakoloji Bülteni 2007; 17: 207-216
18. McIntyre RS, McCann SM, Kennedy SH: Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001;46:273-281
19. Gergerlioglu HS, Savas HA, Celik A, Savas E, Yumru M, Tarakcioglu M, Atmaca M. Atypical antipsychotic usage related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patients. Neuropsychobiology 2006; 53: 108-112
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4.ed, Washington DC, American Psychiatric Association 1994:739-742
21. Expert Panel on Detection and Evaluation of Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
22. Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. B.M.C. Public Health 2006; 6: 92
23. Correll CU, Frederickson AM, Kane JM, Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry 2006; 67: 575-583
24. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47: 913-917
25. Orel M, Lichnovska R, Gwozdziewiczova S, Zlamalova N, Klementa I, Merkunova A, Hrebicek J. Gender differences in tumor necrosis factor alpha and leptin secretion from subcutaneous and visceral fat tissue. Physiol Res 2004; 53: 501-505
26. Hamidi A, Fakhrzadeh H, Moayyeri A, Heshmat R, Ebrahimpour P, Larijani B. Metabolic syndrome and leptin concentrations in obese children. Indian J Pediatr 2006; 73: 593-596
27. Bromel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, Remschmidt H, Krieg JC, Hebebrand J. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 1998; 3: 76-80
28. Kraus T, Haack M, Schuld A, Hinze-Selch D, Kuhn M, Uhr M, Pollmacher T. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 1999; 156: 312-314
29. McIntyre RS, Mancini DA, Basile VS, Srinivasan J, Kennedy SH. Antipsychotic-induced weight gain: bipolar disorder and leptin. Clin Psychopharmacol 2003; 23: 323-327